Skip to content

Arrowhead Research ARWR Intangible assets — net

Intangible assets — net at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
AbbVie logo
AbbVieABBV
Revvity logo
RevvityRVTY
Amgen logo
AmgenAMGN
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's intangible assets — net?
Arrowhead Research (ARWR) reported intangible assets — net of $6.01M in Q1 2026.
How has Arrowhead Research's intangible assets — net changed year-over-year?
Arrowhead Research's intangible assets — net decreased by 22.0% year-over-year, from $7.71M to $6.01M.
What is the long-term trend for Arrowhead Research's intangible assets — net?
Over 5 years (2020 to 2025), Arrowhead Research's intangible assets — net has grown at a -14.9% compound annual growth rate (CAGR), from $15.36M to $6.86M.